J. B. Chemicals & Pharmaceuticals Limited
Symbol: JBCHEPHARM.NS
NSE
1743.85
INRDzisiejsza cena rynkowa
53.2431
Wskaźnik P/E
8.4545
Wskaźnik PEG
270.64B
Kapitalizacja MRK
- 0.01%
Rentowność DIV
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2928.6 | 566.5 | 6936.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 2159.3 | 1.1 | 6649.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 5771.7 | 6238.8 | 4186.7 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 4304.9 | 4099.6 | 3474.5 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 2275.1 | 1843.6 | 928.2 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 15280.3 | 12748.5 | 15526 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5764.2 | 5668.2 | 5696.6 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 574.6 | 574.6 | 574.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 13222.8 | 6713.9 | 321.1 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 13797.4 | 7288.5 | 895.6 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 137.8 | 127.2 | 129.1 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 65.1 | 64.3 | 69.4 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 493.9 | 177.2 | 64.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 20258.4 | 13325.5 | 6855.1 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 2386.4 | 2244.8 | 1869.2 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1739.1 | 339.4 | 398.5 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 49.5 | 60.9 | 79 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3985.4 | 206.2 | 51.4 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | 152.1 | 31.7 | 49.3 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 236.5 | 88.2 | 99.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 5190.7 | 850.7 | 794.1 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 242.1 | 282.4 | 123.4 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 10735.2 | 4687.9 | 4246.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 154.8 | 154.6 | 154.6 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 22757.1 | 18427.1 | 15847.9 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2698.8 | 2248.4 | 1583.6 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -807.1 | 511.2 | 511.2 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 24803.5 | 21341.2 | 18097.2 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 44.9 | 37.1 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 24803.5 | 21386.1 | 18134.3 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 323.9 | 128.1 | 130.9 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 5724.5 | 545.6 | 449.9 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | 4955.2 | -19.9 | 163 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5552.3 | 5049 | 5968.9 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1146.7 | -1685.9 | 0 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 693.7 | 626.5 | 0 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -299.2 | -3025.2 | -942.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | -417.5 | -2928.4 | -706 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -205.2 | -625.1 | -700.9 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | 323.5 | 528.3 | 464.8 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 311.9 | 10.3 | -2565.6 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1998.6 | -7003.9 | -85 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -7568.7 | -5084.7 | -5412.1 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 5570.1 | 12088.6 | 3169.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -1968.4 | 7091.1 | 498.9 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9617.9 | 23.2 | -2306.8 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -872.5 | -3.3 | -3.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 84.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 5684.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -1275.9 | -1275.6 | -732.4 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -55.8 | -105 | -138.6 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3565.4 | -1383.9 | -874.2 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.3 | 0 | 0.4 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 203.9 | 340.7 | -32.8 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 769.3 | 565.4 | 224.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 565.4 | 224.7 | 257.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 6256.1 | 1701.3 | 3147.8 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -1393.4 | -5366.5 | 2670.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 31492.8 | 24242.4 | 20058.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3842.2 | 8633.7 | 7174.4 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 27650.6 | 15608.7 | 12884.1 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 13997.4 | 10862.7 | 8009.7 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3842.2 | 19496.5 | 15184.1 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 25.4 | 9.3 | 17.7 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5917.9 | 4739 | 4895.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 27650.6 | 5049 | 5968.9 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 893.1 | 1188.6 | 1483.6 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 4098.3 | 3853.6 | 4479.6 |
Często zadawane pytania
Ile wynosi J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) aktywów ogółem?
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) całkowite aktywa to 35538700000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.890.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 14.157.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.152.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.855.
Co to jest J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 4098300000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 5724500000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 13997400000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.